RecruitingNot Applicable

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

United States30 participantsStarted 2022-08-31

Plain-language summary

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ≥ 18 years old at the time of informed consent
✓. Written informed consent and HIPAA authorization for release of personal health information.
✓. Active SCLC diagnosis.

What they're measuring

Determining the Feasibility of the Creation of a Rapid Autopsy Program at IUSCCC for SCLC through enrollment and sample collections

Timeframe: 5 years

Utilization of Tissue to Better Understand the Complex Biology of SCLC

Timeframe: 5 years

Trial details

NCT IDNCT05889546

SponsorIndiana University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12-31

Contact for this trial

Gabby Kline, BA

(317) 278-2514 gabkline@iu.edu

View on ClinicalTrials.gov More Small Cell Lung Cancer trials